-
Nobel Prize-winning cancer researcher to deliver keynote address at 2024 SABCS®
Read More: Nobel Prize-winning cancer researcher to deliver keynote address at 2024 SABCS®William G. Kaelin, Jr., MD, will present the keynote address at the 2024 San Antonio Breast Cancer Symposium®. Dr. Kaelin was awarded the 2019 Nobel Prize in Physiology or Medicine for discovering how cells can sense and adapt to changing oxygen availability, paving the way for strategies to combat cancer and other diseases.
-
Plenary Lecture to explore breast cell atlas in cancer prevention, treatment
Read More: Plenary Lecture to explore breast cell atlas in cancer prevention, treatmentWalid Khaled, PhD, will deliver the second plenary lecture during the 2024 San Antonio Breast Cancer Symposium® about cell atlases as roadmaps in cancer immunology.
-
Pioneering molecular biologist to present 2024 McGuire Lecture
Read More: Pioneering molecular biologist to present 2024 McGuire LectureLaura J. van ‘t Veer, PhD, will receive the William L. McGuire Memorial Lecture Award in recognition of advancing risk stratification, subtyping, and improving treatment for early breast cancer.
-
Special session to explore dynamics of metabolic health and breast cancer prevention
Read More: Special session to explore dynamics of metabolic health and breast cancer preventionCarol Fabian, MD, will moderate a panel discussion about approaches to risk reduction and the mechanisms of obesity-related risk for breast cancer.
-
Plenary Lecture to untangle drivers of racial disparities in breast cancer
Read More: Plenary Lecture to untangle drivers of racial disparities in breast cancerMelissa Davis, PhD, will deliver a plenary lecture during the 2024 San Antonio Breast Cancer Symposium® about the social and biological drivers that underlie racial disparities in breast cancer outcomes.
-
‘Sex, Drugs, Rock and Roll’ special session to address lifestyle decisions in breast cancer treatment
Read More: ‘Sex, Drugs, Rock and Roll’ special session to address lifestyle decisions in breast cancer treatmentChristine Ambrosone, PhD, will moderate a panel discussion on questions patients may have related to cannabis use during treatment and other personal choices.
-
Key sessions to focus on artificial intelligence in breast cancer
Read More: Key sessions to focus on artificial intelligence in breast cancerThe 2024 SABCS® will explore the hype and reality of AI during two sessions, including a discussion on revolutionizing diagnosis and discovery, moderated by Frederick Howard, MD.